At a glance
- Originator Auckland Cancer Society Research Centre
- Class Cytostatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Jul 1998 Profile reviewed
- 17 Mar 1995 Preclinical development for Cancer in New Zealand (Unknown route)